Expression profiling of supraglottic carcinoma: PTEN and thrombospondin 2 are associated with inhibition of lymphatic metastasis

Acta Otolaryngol. 2009 May;129(5):569-74. doi: 10.1080/00016480802294351.

Abstract

Conclusion: Down-regulation of metastasis inhibitor genes PTEN and thrombospondin 2 may play a role in the lymphatic metastasis of supraglottic carcinoma.

Objectives: To investigate differentially expressed genes in supraglottic squamous cell carcinoma with and without lymphatic metastasis using cDNA microarray.

Materials and methods: cDNA microarray was used to detect the expression profiles of supraglottic carcinoma and the results were validated with real-time PCR.

Results: Compared with normal laryngeal tissues, the expression of 15.6% (15/96) genes including cathepsin B, cathepsin D, cathepsin L, Ets1, c-Ets2, and PEA3 were up-regulated in both cases of supraglottic carcinoma. Compared with the supraglottic carcinoma with no lymph node metastasis, the expression of metastasis inhibitor genes PTEN and thrombospondin 2 was down-regulated in the supraglottic carcinoma tissue with lymph node metastasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / secondary*
  • Down-Regulation
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic / genetics*
  • Humans
  • Laryngeal Neoplasms / genetics*
  • Lymphatic Metastasis / genetics
  • Lymphatic Metastasis / prevention & control
  • Male
  • Oligonucleotide Array Sequence Analysis
  • PTEN Phosphohydrolase / metabolism*
  • Thrombospondins / metabolism*

Substances

  • Thrombospondins
  • thrombospondin 2
  • PTEN Phosphohydrolase
  • PTEN protein, human